Tailored enrichment strategy detects low abundant small noncoding RNAs in HIV-1 infected cells

被引:32
|
作者
Althaus, Claudia F. [1 ]
Vongrad, Valentina [1 ]
Niederoest, Barbara [1 ]
Joos, Beda [1 ]
Di Giallonardo, Francesca [1 ]
Rieder, Philip [1 ]
Pavlovic, Jovan [2 ]
Trkola, Alexandra [2 ]
Guenthard, Huldrych F. [1 ]
Metzner, Karin J. [1 ]
Fischer, Marek [1 ]
机构
[1] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, CH-8091 Zurich, Switzerland
[2] Univ Zurich, Inst Med Virol, CH-8091 Zurich, Switzerland
来源
RETROVIROLOGY | 2012年 / 9卷
基金
瑞士国家科学基金会;
关键词
HIV-1; Small noncoding RNA; Antisense RNA; Hybridization capture; DOUBLE-STRANDED-RNA; ANTIRETROVIRAL THERAPY; HIV-1; MICRORNAS; VIRUS; IDENTIFICATION; INTERFERENCE; EXPRESSION; TRANSCRIPTS; MECHANISMS;
D O I
10.1186/1742-4690-9-27
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: The various classes of small noncoding RNAs (sncRNAs) are important regulators of gene expression across divergent types of organisms. While a rapidly increasing number of sncRNAs has been identified over recent years, the isolation of sncRNAs of low abundance remains challenging. Virally encoded sncRNAs, particularly those of RNA viruses, can be expressed at very low levels. This is best illustrated by HIV-1 where virus encoded sncRNAs represent approximately 0.1-1.0% of all sncRNAs in HIV-1 infected cells or were found to be undetected. Thus, we applied a novel, sequence targeted enrichment strategy to capture HIV-1 derived sncRNAs in HIV-1 infected primary CD4(+) T-lymphocytes and macrophages that allows a greater than 100-fold enrichment of low abundant sncRNAs. Results: Eight hundred and ninety-two individual HIV-1 sncRNAs were cloned and sequenced from nine different sncRNA libraries derived from five independent experiments. These clones represent up to 90% of all sncRNA clones in the generated libraries. Two hundred and sixteen HIV-1 sncRNAs were distinguishable as unique clones. They are spread throughout the HIV-1 genome, however, forming certain clusters, and almost 10% show an antisense orientation. The length of HIV-1 sncRNAs varies between 16 and 89 nucleotides with an unexpected peak at 31 to 50 nucleotides, thus, longer than cellular microRNAs or short-interfering RNAs (siRNAs). Exemplary HIV-1 sncRNAs were also generated in cells infected with different primary HIV-1 isolates and can inhibit HIV-1 replication. Conclusions: HIV-1 infected cells generate virally encoded sncRNAs, which might play a role in the HIV-1 life cycle. Furthermore, the enormous capacity to enrich low abundance sncRNAs in a sequence specific manner highly recommends our selection strategy for any type of investigation where origin or target sequences of the sought-after sncRNAs are known.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Zinc-Finger Nucleases Induced by HIV-1 Tat Excise HIV-1 from the Host Genome in Infected and Latently Infected Cells
    Ji, Haiyan
    Lu, Panpan
    Liu, Baochi
    Qu, Xiying
    Wang, Yanan
    Jiang, Zhengtao
    Yang, Xinyi
    Zhong, Yangcheng
    Yang, He
    Pan, Hanyu
    Zhao, Lin
    Xu, Jianqing
    Lu, Hongzhou
    Zhu, Huanzhang
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2018, 12 : 67 - 74
  • [42] Frequent detection of HIV-1 RNA but low rates of HIV-1 isolation in cervicovaginal secretions from infected women
    Saracino, A
    Di Stefano, M
    Fiore, JR
    Lepera, A
    Raimondi, D
    Angarano, G
    Pastore, G
    MICROBIOLOGICA, 2000, 23 (01): : 79 - 83
  • [43] Association Between Low HIV-1 DNA and Western Blot Reactivity to HIV-1 Pol in Chronically Infected Individuals
    Muccini, Camilla
    Galli, Laura
    Spagnuolo, Vincenzo
    Poli, Andrea
    Rolla, Serena
    Mastrangelo, Andrea
    Rinaldi, Francesca
    Castagna, Antonella
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 82 (04) : 373 - 376
  • [44] Low levels of HIV-1 plasma viral load in patients infected with HIV-1 subtype B and advanced immunosuppression
    de la Rosa, R
    Leal, M
    Pineda, JA
    Dietrich, U
    Delgado, J
    Macías, J
    Rubio, A
    Sánchez-Quijano, A
    Lissen, E
    JOURNAL OF INFECTION, 2001, 42 (01) : 4 - 7
  • [45] Identification of a Cluster of HIV-1 Controllers Infected with Low Replicating Viruses
    Casado, Concepcion
    Pernas, Maria
    Sandonis, Virginia
    Alvaro-Cifuentes, Tamara
    Olivares, Isabel
    Fuentes, Rosa
    Martinez-Prats, Lorena
    Grau, Eulalia
    Ruiz, Lidia
    Delgado, Rafael
    Rodriguez, Carmen
    del Romero, Jorge
    Lopez-Galindez, Cecilio
    PLOS ONE, 2013, 8 (10):
  • [46] Deep sequencing of virus-infected cells reveals HIV-encoded small RNAs
    Schopman, Nick C. T.
    Willemsen, Marcel
    Liu, Ying Poi
    Bradley, Ted
    van Kampen, Antoine
    Baas, Frank
    Berkhout, Ben
    Haasnoot, Joost
    NUCLEIC ACIDS RESEARCH, 2012, 40 (01) : 414 - 427
  • [47] Effective small interfering RNAs targeting alphaV integrin inhibit HIV-1 replication
    Pauls, Eduardo
    Ballana, Ester
    Clotet-Codina, Imma
    Bosch, Berta
    Perron-Sierra, Francoise
    Tucker, Gordon
    Clotet, Bonaventura
    Este, Jose
    ANTIVIRAL RESEARCH, 2008, 78 (02) : A28 - A28
  • [48] Interleukin-10 gene expression induced by HIV-1 Tat and Rev in the cells of HIV-1 infected individuals
    Blazevic, V
    Heino, M
    Lagerstedt, A
    Ranki, A
    Krohn, KJE
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1996, 13 (03) : 208 - 214
  • [49] Evaluation of the Roche COBAS® TaqMan® HIV-1 test for quantifying HIV-1 RNA in infected cells and lymphoid tissue
    Gil, Cristina
    Teresa Garcia, M.
    Garcia, Felipe
    Miro, Jose M.
    Agueero, Fernando
    Alos, Lucia
    Zamora, Laura
    Capon, Alicia
    Costa, Josep
    Pumarola, Tomas
    Gatell, Jose M.
    JOURNAL OF VIROLOGICAL METHODS, 2011, 174 (1-2) : 69 - 76
  • [50] Immunological and pharmacological strategies to reactivate HIV-1 from latently infected cells: a possibility for HIV-1 paediatric patients?
    Martinez-Bonet, M.
    Clemente, M. I.
    Serramia, M. J.
    Moreno, S.
    Munoz, E.
    Munoz-Fernandez, M. A.
    JOURNAL OF VIRUS ERADICATION, 2015, 1 (03) : 148 - 152